X-ray computed tomography

Global Computed Tomography Market (2020 to 2025) - Featuring Canon, GE Healthcare and Siemens Healthineers Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021
Medical devices, Health, X-ray computed tomography, Medicine, Clinical medicine, Radiology, Health care, Projectional radiography, Medical imaging, CT scan, Multidimensional signal processing, Computed tomography angiography, Angiography, Pulmonary embolism

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%-4%.

Key Points: 
  • An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%-4%.
  • CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management.
  • The dynamic CT industry involves many participants introducing technological innovations frequently to match the rapidly evolving needs of clinicians, radiologists, and technologists.
  • Coronary CT angiography is the most commonly used imaging modality to diagnose pulmonary embolism and will remain so during the forecast period.

Worldwide Dental Cone Beam Computed Tomography Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021
Dental, Health, Dentistry, Multidimensional signal processing, Cone beam computed tomography, X-ray computed tomography, Marketplace, CT scan, Health sciences, Health care, Medicine

The report on dental cone beam computed tomography market covers the following areas:

Key Points: 
  • The report on dental cone beam computed tomography market covers the following areas:
    The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
  • It presents various market facets by identifying the key industry influencers.
  • The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

RapidAI Launches Rapid Workflow for Pulmonary Embolism (PE)

Retrieved on: 
Thursday, June 24, 2021
Medical specialties, Cardiovascular system, Hematology, Circulatory system, Medical emergencies, Pulmonary embolism, Embolism, Pulmonary artery, Tissue plasminogen activator, Thrombus, X-ray computed tomography, Hypertension

SAN MATEO, Calif., June 24, 2021 /PRNewswire/ -- RapidAI , leading the next evolution of clinical decision making and patient workflow, today announced the availability of Rapid Workflow for PE , a mobile and web-based app designed to align hospital teams on the treatment of patients suspected of having a pulmonary embolism.

Key Points: 
  • SAN MATEO, Calif., June 24, 2021 /PRNewswire/ -- RapidAI , leading the next evolution of clinical decision making and patient workflow, today announced the availability of Rapid Workflow for PE , a mobile and web-based app designed to align hospital teams on the treatment of patients suspected of having a pulmonary embolism.
  • Pulmonary embolism is a sudden blockage of one or more pulmonary arteries caused by a blood clot.
  • "Rapid Workflow for PE is the next step in our journey to improving patient care," Don Listwin, CEO of RapidAI said.
  • Collaborating with RapidAI has allowed us to utilize their platform, first used to streamline the workflow in stroke, and bring this technology into the pulmonary embolism space.

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

Retrieved on: 
Monday, June 14, 2021
Breast cancer, Tomosynthesis, X-ray computed tomography, DBT, Cancer screening, Health, Breast imaging, Clinical medicine, Ontology

(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) received CE Mark approval.

Key Points: 
  • (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) received CE Mark approval.
  • Built with the latest in deep-learning technology, ProFound AI for DBT Version 3.0 rapidly analyzes each tomosynthesis image, detecting malignant soft tissue densities and calcifications with unrivaled accuracy.
  • Since obtaining CE Mark certification with our first generation of this technology in July 2019, ProFound AI has been installed in a growing number of medical imaging centers across Europe.
  • ProFound AI is fully in line with this desire to constantly improve radiologists abilities to detect breast cancer as early as possible.

Global Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) Market Trajectory & Analytics Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Radiology, Health, X-ray computed tomography, Cone beam computed tomography, Dentistry, CBCT, Applied mathematics, Compound annual growth rate, FPD, CT scan, Health sciences, Medicine

b'The "Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.\nOrthopedics, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$2.3 Billion by the end of the analysis period.

Key Points: 
  • b'The "Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com\'s offering.\nAmid the COVID-19 crisis, the global market for Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.\nOrthopedics, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$2.3 Billion by the end of the analysis period.
  • After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dental segment is readjusted to a revised 7.6% CAGR for the next 7-year period.\nThe U.S. Market is Estimated at $603.9 Million, While China is Forecast to Grow at 10.4% CAGR\nThe Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT) market in the U.S. is estimated at US$603.9 Million in the year 2020.
  • Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.\nIn the global ENT segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484.4 Million by the year 2027, while Latin America will expand at a 8.5% CAGR through the analysis period.\n'

MedShape And CurveBeam Announce Initiation of Joint Prospective Clinical Study

Retrieved on: 
Monday, May 10, 2021
Surgical specialties, Cone beam computed tomography, Dentistry, X-ray computed tomography, Orthopedic surgery

b'ATLANTA, May 10, 2021 /PRNewswire/ -- MedShape, Inc., recently acquired by DJO as well as the orthopedic industry leader in promoting active, adaptive healing technologies, and CurveBeam, the leader in weight-bearing CT (WBCT) imaging, jointly announced today the initiation of a new prospective clinical study with the Orthopaedic Foot & Ankle Center (Dublin, OH).

Key Points: 
  • b'ATLANTA, May 10, 2021 /PRNewswire/ -- MedShape, Inc., recently acquired by DJO as well as the orthopedic industry leader in promoting active, adaptive healing technologies, and CurveBeam, the leader in weight-bearing CT (WBCT) imaging, jointly announced today the initiation of a new prospective clinical study with the Orthopaedic Foot & Ankle Center (Dublin, OH).
  • "With this study, we will be able to assess when and where specifically bone growth occurs and compare this growth pattern amongst different patient groups with various challenging co-morbidities.
  • For more information, visit: http://www.medshape.com .\nCurveBeam researches, designs and manufactures cone beam CT imaging systems for the orthopedic specialties.
  • Comparison of Tibiotalocalcaneal Arthrodeses Using a Sustained Dynamic Compression Nail Versus Nondynamized Nails.Foot & Ankle Spec, 2020; 13(3): 193-200.\nDynaNail is a registered trademark of MedShape, Inc.

Major independent study shows Transpara® AI by ScreenPoint Medical can reduce radiologists' workload up to 70% for both 2D and 3D mammography

Retrieved on: 
Thursday, May 6, 2021
Medicine, Cancer screening, Clinical medicine, Breast imaging, Projectional radiography, Medical tests, Breast cancer, Tomosynthesis, X-ray computed tomography, Mammography, Screening, Radiology

The authors also found that using Transpara AI to transition from 2D to 3D mammography (digital breast tomosynthesis) screening would yield a 30% reduction in workload, a 25% improvement in sensitivity and a 27% reduction in the screening recall rate.

Key Points: 
  • The authors also found that using Transpara AI to transition from 2D to 3D mammography (digital breast tomosynthesis) screening would yield a 30% reduction in workload, a 25% improvement in sensitivity and a 27% reduction in the screening recall rate.
  • Furthermore, many countries are challenged with the backlog of diagnosed cancer cases due to Covid-19 screening delays.
  • The higher the number the higher the risk, enabling radiologists to focus on those women facing the highest risk.
  • This saving is so important as there is a global shortage of radiologists, with workload also on the increase due to the introduction of new imaging techniques such as 3D breast tomosynthesis."

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

Retrieved on: 
Monday, April 19, 2021
Articles, Clinical medicine, Breast cancer, Tomosynthesis, X-ray computed tomography, Academic disciplines, DBT, Biopsy, Artificial intelligence

\xe2\x80\x9cIn addition, ProFound AI is clinically proven to improve radiologists\xe2\x80\x99 sensitivity while simultaneously improving their specificity, which is a huge performance achievement in breast care.

Key Points: 
  • \xe2\x80\x9cIn addition, ProFound AI is clinically proven to improve radiologists\xe2\x80\x99 sensitivity while simultaneously improving their specificity, which is a huge performance achievement in breast care.
  • Researchers used ProFound AI on 890 consecutive DBT studies and 50 consecutive cases with biopsy-proven breast cancer detected with DBT.
  • Built with the latest in deep-learning technology, ProFound AI for DBT rapidly analyzes each tomosynthesis image, detecting malignant soft tissue densities.
  • Certainty of Finding and Case Scores are relative scores computed by the ProFound AI algorithm and represent its confidence that a detection or case is malignant.

Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance

Retrieved on: 
Tuesday, April 6, 2021
Medicine, Medical imaging, Clinical medicine, Health sciences, Medical physics, Radiology, Cone beam computed tomography, Dentistry, X-ray computed tomography, Interventional radiology, CT scan, Philips

SmartCT is a key component of Philips Image Guided Therapy System Azurion providing interventionalists with CT-like 3D images (Cone Beam CT) to support diagnosis, therapy planning, treatment and follow-up for interventional radiology procedures.

Key Points: 
  • SmartCT is a key component of Philips Image Guided Therapy System Azurion providing interventionalists with CT-like 3D images (Cone Beam CT) to support diagnosis, therapy planning, treatment and follow-up for interventional radiology procedures.
  • SmartCT brings total control of the Azurion platform to a touchscreen tablet situated alongside the interventional radiology table.
  • With SmartCT, users are guided through the image acquisition process and can review and interact with the acquired CT-like 3D images on the systems table-side touch screen module using 3D visualization and measurement tools.
  • Philips SmartCT image acquisition, visualization and measurement software is an integral part of the next-generation Philips Image Guided Therapy System Azurion which was launched in September 2020, marking an important step forward in optimizing clinical and operational lab performance and expanding the role of image-guided interventions in the treatment of patients.

RadSite Launches Dental and Medical Cone Beam CT Accreditation Programs

Retrieved on: 
Tuesday, March 23, 2021
Medical physics, Neuroimaging, Medicine, Clinical medicine, Branches of biology, X-ray computed tomography, Radiobiology, Single-photon emission computed tomography, CT scan, PET-CT, Cone beam computed tomography

ANNAPOLIS, Md., March 23, 2021 /PRNewswire-PRWeb/ -- RadSite, a leading accrediting organization promoting performance and quality-based imaging practices, announced today that it is offering two new accreditation programs for Cone Beam CT imaging suppliers, Dental and Medical.

Key Points: 
  • ANNAPOLIS, Md., March 23, 2021 /PRNewswire-PRWeb/ -- RadSite, a leading accrediting organization promoting performance and quality-based imaging practices, announced today that it is offering two new accreditation programs for Cone Beam CT imaging suppliers, Dental and Medical.
  • Dr. Harrell is the chair of RadSite's Cone Beam CT Standards Committee and Assistant Associate Professor at the University of Alabama, Birmingham.
  • He adds: "The Standards Committee spent many hours discussing key performance and practice parameters that Cone Beam CT imaging suppliers should adhere to."
  • The new Cone Beam CT Standards supplement RadSite's MAP ADI accreditation programs covering CT, MRI, and Nuclear Medicine (i.e., PET, PET/CT and SPECT) for imaging suppliers.